Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
Abstract Rapid-response vaccine production platform technologies, including RNA vaccines, are being developed to combat viral epidemics and pandemics. A key enabler of rapid response is having quality-oriented disease-agnostic manufacturing protocols ready ahead of outbreaks. We are the first to app...
Guardado en:
Autores principales: | Damien van de Berg, Zoltán Kis, Carl Fredrik Behmer, Karnyart Samnuan, Anna K. Blakney, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07c8cff71bf445a6a6254505e668c398 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
por: Alexandra J. Spencer, et al.
Publicado: (2021) -
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
por: Paul F. McKay, et al.
Publicado: (2020) -
ETHICAL AND LEGAL ASPECTS OF INFECTIOUS DISEASES AND VACCINATION Part 3. Ethical principals of eradication of infectious diseases
por: O. I. Kubar, et al.
Publicado: (2014) -
ETHICAL AND LEGAL ASPECTS OF INFECTIOUS DISEASES AND VACCINATION. Part 2. Ethical aspects of planning and conducting of research in the field of vaccine prevention
por: O. I. Kubar, et al.
Publicado: (2014) -
Lassa virus: characterization of infectious agent, biological models for pathogenesis studies and variants of vaccine
por: E. I. Kazachinskaya, et al.
Publicado: (2021)